|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The data originated from the follow-up survey (2011 and 2013-2015) of the China Health and Retirement Longitudinal Study (CHARLS) and included 3337 residents aged at least 45 years who completed a physical examination and were evaluated with the Center for Epidemiological Studies Depression Scale (CES-D-10), which assessed depressive symptoms.
|
30041632 |
2018 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Symptoms of depression were assessed using the Center for Epidemiology Studies Depression Scale (CES-D) and the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D).
|
19674795 |
2010 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
A CES-D score ≥ 19 combined with self-reported limitations related to depressive symptoms was used to define depression.
|
30296663 |
2019 |
|
Depressive Symptoms
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The CES-D may also be a good choice when sampling students with elevated levels of depressive symptoms.
|
27322202 |
2017 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Depressive symptoms (years 15, 20, 25) were assessed with the Center for Epidemiologic Studies Depression (CES-D) scale; LTL (years 15, 20, 25) and mtDNAcn (years 15, 25) were measured in whole blood by quantitative PCR.
|
28348385 |
2018 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The Center for Epidemiological Studies-Depression Scale (CES-D) was used to assess depressive symptoms.
|
29747138 |
2018 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The main outcome measures were elevated depressive symptoms ≥16 on the CES-D, and/or elevated anxiety symptoms >10 on the GAD-7 score.
|
31166310 |
2019 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Major depressive disorder (MDD) was diagnosed according to DSM-IV (American Psychiatric Association, 1994) criteria, and severe depressive symptoms assessed by the Centre for Epidemiological Studies Depression (CES-D) Scale.
|
30180828 |
2018 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The Center for Epidemiologic Studies Depression Scale (CES-D) was used to measure depressive symptoms.
|
21597034 |
2011 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Self-reports of short (<6 h), intermediate (6-8 h) and long (≥9 h) sleep were assessed prior to the initial CES-D. Logistic regression was used to evaluate the cross-sectional associations between short and long sleep durations with depressive symptoms, using intermediate sleep as the reference.
|
29221780 |
2017 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
After adjusting for adolescent and family covariates, DMPU ≥ 2 h/day on weekdays (OR = 1.78, 95%CI = 1.48-2.15) and ≥ 5 h/day on the weekend (OR = 1.67, 95%CI = 1.41-1.98) was associated with increased risk of depressive symptoms as assessed by CES-D.
|
31450134 |
2019 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The main outcome measures were elevated depressive symptoms ≥16 on the CES-D, and/or elevated anxiety symptoms >10 on the GAD-7 score.
|
31453968 |
2019 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Pearson correlation analysis results showed: CES-D was significantly (<i>P</i> < 0.01) and positively correlated with IAII(<i>r</i> = 0.640); CES-D was negatively correlated with SRSS (<i>r</i> = -0.364) and CD-RISC (<i>r</i> = -0.393); The mediating effect results showed that internet addiction partially mediated the association between social support and depressive symptoms (64.9% proportion mediated).
|
31630539 |
2020 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
We analyzed data on candidate SNPs for the HPA-axis, genome-wide scans, cortisol secretion (n=1711) and depressive symptoms (the Centre for Epidemiology Studies Depression Scale, CES-D) (n=2928) in elderly persons of the Rotterdam Study.
|
21316860 |
2011 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Depressive symptoms were measured using the Center for Epidemiologic Studies Depression Scale (CES-D-10) and was classified into absence or presence of depressive symptoms.
|
29076031 |
2017 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
CES-D correlations were 0.38 (95% CI 0.28-0.46) for MZ twins and 0.24 (95% CI 0.14-0.36) for DZ twins.Greater eveningness (i.e. lower MEQ scores) was significantly related to more depression symptoms (phenotypic correlation = -0.15 (95% CI -0.21 to -0.09).
|
25347156 |
2015 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The association between both major and everyday discrimination and depressive symptoms, as measured by the Center for Epidemiologic Studies Depression (CES-D) scale, was assessed among 296 African American men in the 2011-2014 Nashville Stress and Health Study (NSAHS) using ordinary least squares regression.
|
28977662 |
2018 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
A substantial portion (34.5%) of participants reported depressive symptoms at a level associated with clinically significant levels of depression (>or=16 on the CES-D).
|
16783123 |
2006 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Depressive symptoms were diagnosed using the 20-item Center for Epidemiologic Studies-Depression (CES-D) ≥ 16.
|
30959758 |
2019 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Depressive symptoms were assessed using the Center of Epidemiologic Studies Depression (CES-D) scale.
|
20468063 |
2010 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Depressive symptoms were measured with the Center for Epidemiological Studies-Depression Scale (CES-D); higher scores indicated more depressive symptoms.
|
29762643 |
2018 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Depressive symptoms were assessed using BDI (cutoffs 13 and 15), CES-D and HADS.
|
28587586 |
2018 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
We proposed a model in which walking for a purpose during pregnancy mediated the effects of symptoms of depression (measured by the 20-item Center for Epidemiologic Studies-Depression [CES-D] scale) on gestational age at birth in a sample of 1,382 African American women.
|
28215983 |
2017 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Morbidly obese patients with knee pain on most days were evaluated before bariatric surgery or medical weight management and at 1-year follow-up for BML and synovitis seen on MRI, pressure pain threshold (PPT) at patella and right wrist, depressive symptoms (using CES-D), and WOMAC pain survey.
|
31562683 |
2020 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Depressive symptoms were assessed in 2010/11 and 2016/17 using the 8-item centre for Epidemiologic Studies Depression (CES-D) scale.
|
31846900 |
2020 |